Company Analysis HealthCare Global Enterprises Limited
1. Summary
Advantages
- The stock's return over the last year (50.64%) is higher than the sector average (17.06%).
Disadvantages
- Price (560.1 βΉ) is higher than fair price (46.54 βΉ)
- Dividends (0%) are below the sector average (9.04%).
- Current debt level 47.07% has increased over 5 years from 36.35%.
- The company's current efficiency (ROE=5.71%) is lower than the sector average (ROE=10.54%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| HealthCare Global Enterprises Limited | Healthcare | Index | |
|---|---|---|---|
| 7 days | -10.3% | 0.8% | 1.2% |
| 90 days | 5.6% | 7.6% | 10.9% |
| 1 year | 50.6% | 17.1% | 9.8% |
HCG vs Sector: HealthCare Global Enterprises Limited has outperformed the "Healthcare" sector by 33.59% over the past year.
HCG vs Market: HealthCare Global Enterprises Limited has outperformed the market by 40.83% over the past year.
Stable price: HCG is not significantly more volatile than the rest of the market on "National Stock Exchange Of India" over the last 3 months, with typical variations of +/- 5% per week.
Long period: HCG with weekly volatility of 0.9739% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (560.1 βΉ) is higher than the fair price (46.54 βΉ).
Price is higher than fair: The current price (560.1 βΉ) is 91.7% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (99.4) is higher than that of the sector as a whole (59.66).
P/E vs Market: The company's P/E (99.4) is higher than that of the market as a whole (65.28).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (5.53) is lower than that of the sector as a whole (6.61).
P/BV vs Market: The company's P/BV (5.53) is lower than that of the market as a whole (6.43).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.53) is lower than that of the sector as a whole (9.33).
P/S vs Market: The company's P/S indicator (2.53) is lower than that of the market as a whole (18.87).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (16.52) is lower than that of the sector as a whole (141.68).
EV/Ebitda vs Market: The company's EV/Ebitda (16.52) is lower than that of the market as a whole (24.54).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -29.03% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-29.03%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-3.49%).
5.4. ROE
ROE vs Sector: The company's ROE (5.71%) is lower than that of the sector as a whole (10.54%).
ROE vs Market: The company's ROE (5.71%) is higher than that of the market as a whole (3.54%).
5.5. ROA
ROA vs Sector: The company's ROA (1.92%) is lower than that of the sector as a whole (7.51%).
ROA vs Market: The company's ROA (1.92%) is lower than that of the market as a whole (7.88%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.95%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (15.48%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '9.04%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
